Author: kmenke
‘Fight for 15’ Debate: What Happens after a Big Boost in Minimum Wage?
Modest loss of jobs followed 1966 law, but millions won substantial raises
“How’re Sales, Roger?” “Good Question, Roger!”
When CEO and analyst share a first name, earnings estimates are sharper
#MeToo: Company Responses to Harassment Claims Can Mitigate Reputation Damage
New research looks beyond attitudes toward specific executives accused of harassment to focus on people’s perceptions of corporatewide gender culture.
‘They Were Already Inside My Head To Begin With’
The ethics of asking brain surgery patients to allow unrelated research while on the operating table
Carbon Disclosures: Unflattering Supply Chain Data Omitted
Companies that report emissions appear greener only in a narrow measure
How Oil Prices Distort Our View of Inflation
A favored Federal Reserve index fails to filter out petroleum’s impact
How to Reduce Food-Delivery Collisions
Fining drivers hasn’t worked. A model suggests penalizing the delivery app companies
Migration — and Home Price Escalation — Happens Along Established Routes
Major cities reliably feed residents to the same smaller markets, and housing booms predictably travel with them
Mobile Banking, a Boon to Many, Disadvantages Those Who Bank at Branches
Banks close neighborhood outlets and raise prices for branch-delivered services
Muni Bond Buyers Pay a Little Extra for the Pleasure of Not Being Taxed
Doing so, they subsidize government, which is, well, sort of like a tax
Proposed: Give Consumers on Amazon a Direct Line to Small Business Products
Third-party sellers would gain; consumers might pay more but increase control of products display
The Behavior of Companies Straining to Meet Earnings Forecasts
Plus: home buyers after they collect big equity gains, math and gender, and who votes
What Investors Infer From External News And Management Silence
Uncertainty about outside news alters company disclosures and how markets interpret them, study finds
Why We Think Differently About Money Than About Probabilities
Learning gradually versus all at once and how we estimate value
$52.6 Billion: Extra Cost to Consumers of Add-On Drug Patents
The figure is a subset, not covering huge expense of extended patents on high-priced biologics like Humira